This week, the FTC ordered Cerebral to pay a $7 million fine, accusing the company of mishandling users’ sensitive health ...

Two Chairs, a startup offering hybrid behavioral health care, closed a $72 million Series C funding round. The company’s ...

A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different ...

Pelago, a virtual clinic for substance use treatment, launched a contingency management program, in which members are rewarded for healthy behaviors like engaging in treatment, the company ...

Ilant Health, a virtual obesity management company, announced Wednesday that it extended its seed round from $3 million to $5.5 million. New York City-based Ilant Health is a value-based care ...

Carrie Lester looks forward to the phone call every Thursday from her doctors’ medical assistant, who asks how she’s doing and if she needs prescription refills. The assistant counsels her on ...

Don’t be surprised if soon there’s a supply chain shortage of expert witnesses for medical malpractice and other healthcare lawsuits. The scarcity would come from an upswing in demand that ...

An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug ...

A Roche cancer drug that treats lung cancer with a certain genetic signature now has an additional FDA approval that expands the applications of the blockbuster product. The drug, Alecensa, is ...

When it comes to evaluating the health of a patient, each therapeutic area has its own data-gathering tools. Think glucose monitors in diabetes and heart monitors for cardiovascular disease.